Fletcher Payne is listed as an executive officer on 5 SEC Form D filings by 3 issuers between Oct 2010 and Jul 2015: CytomX Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2012; $70M reported sold to 33 investors), CATALYST BIOSCIENCES INC (South San Fransicso, CA — biotechnology — 2015; $40.4M reported sold to 21 investors) and PATHWORK DIAGNOSTICS INC (Redwood City, CA — biotechnology — 2010; $26.3M reported sold to 18 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer, over about 5 years. Across those companies the filings report $136.7M sold in total.
Listed alongside Asish Xavier (2 shared filings), Augustine Lawlor (2 shared filings), David Mack (2 shared filings), Deborah J. Neff (2 shared filings), Greg Lahann (2 shared filings) and 15 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Fletcher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below. Not yet searched: SEC enforcement releases.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.